跳到正文

Novavax(NOVAVAX INC)提交8-K,披露Regulation FD与其它事件

SEC EDGAR 8-K·(美东 10月29日 16:30)· 3 天前

8-K - NOVAVAX INC (0001000694) (Filer)

AI 导读

据SEC EDGAR,Novavax(NOVAVAX INC,CIK 0001000694)于2026-10-29提交8-K,申报日期与受理日期均为2026-10-29,受理时间为16:30:21,报告期为2026-10-29,共12份文件。

报错 · 内容有误?请告诉我们。

正文 · 原文

Filing Date

2026-10-29

Accepted

2026-10-29 16:30:21

Documents

12

Period of Report

2026-10-29

Items

Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Mailing Address 21 FIRSTFIELD RD GAITHERSBURG MD

Business Address 21 FIRSTFIELD RD GAITHERSBURG MD 240-268-2000

NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 261502295
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

来源:SEC EDGAR 8-K · sec.gov